INTRODUCTION
Alcohol use and abuse are prevalent and impose significant health burdens in our society.
A recent national survey suggests that more than half of the population in the United States above the age of 12 consumes alcohol (1) and the lifetime prevalence of alcohol abuse is 18 percent (2). Tragically, alcohol abuse is the third leading cause of preventable death in the United States (3), and alcoholism is associated with numerous chronic, non-fatal health implications as well. The overall annual cost of alcohol abuse to American society has been estimated to be upwards of $200 billion dollars (4) .
The consequences of alcoholism span multiple organ systems, including the heart, liver, brain, and skeletal muscle (5, 6) . Among these widespread effects, alcohol abuse renders individuals susceptible to pulmonary infections and acute lung injury (7) (8) (9) (10) . We have explored potential mechanisms in experimental animal models and determined that chronic alcohol ingestion causes previously unrecognized cellular dysfunction and oxidative stress, as best reflected by significant decreases in glutathione levels, within the alveolar space (11) (12) (13) (14) . Alveolar macrophages, which are the primary immune cell in the lower airways, exhibit impaired phagocytosis and respiratory burst generation in animal models of chronic alcohol ingestion (15, 16) , and treatment with anti-oxidants reverses these defects (17, 18) . In addition, we established that decreased signaling of granulocyte/macrophage colony-stimulating factor (GM-CSF) mediates alcohol-induced alveolar macrophage immune deficiency (13, 19) . GM-CSF is vital for the alveolar macrophage to achieve appropriate maturity, to complete terminal differentiation, and to maintain normal functioning (20) .
More recently, animal models implicate zinc deficiency as a fundamental mechanism that drives the oxidative stress and impaired GM-CSF signaling in the alcoholic lung (21) . Zinc is a trace metal that is an important co-factor for numerous enzymes in the body and plays a key role in the immune response (22) . Zinc deficiency has been implicated in the development of pneumonia in children of third world countries (23, 24) , and dietary zinc supplementation in these children decreases susceptibility to infection and improves overall health outcomes (25, 26) . Importantly, recent experimental studies have shown that alcohol-fed animals have lower zinc levels in the lung compared to control-fed animals, and dietary zinc supplementation can reverse the pulmonary immune dysfunction seen with chronic alcohol ingestion (21, 27) .
While these and other experimental models are important to our understanding of the alcohol lung phenotype, human studies are lacking. For this reason, we undertook this study to establish if alveolar macrophages from otherwise healthy alcoholics have significantly reduced intracellular zinc levels and phagocytic function compared to non-alcoholics, and to determine the effect of treating these alveolar macrophages in vitro with zinc and/or glutathione precursors.
To answer these questions, we obtained alveolar macrophages via bronchoalveolar lavage from otherwise healthy alcoholic and non-alcoholic individuals and compared their relative intracellular levels of zinc, surface expression of the GM-CSF receptor, and phagocytic function.
In parallel, we determined whether we could enhance the functional status of alveolar macrophages from alcoholics by treating them with zinc and glutathione in vitro as a pre-clinical proof-of-principle that dietary supplementation could enhance lung health in these vulnerable individuals. Some of the results of these studies have been previously reported in the form of an abstract (28) .
METHODS

Study population.
The target population was otherwise healthy adults (18-55 years of age) who were diagnosed with an alcohol use disorder (AUD) at the time of enrollment. An AUD was defined as having a positive Short Michigan Alcohol Screening Test (SMAST) (29) and this was later confirmed with the Alcohol Use Disorders Identification Test (AUDIT) (30) . All subjects were recruited from the Substance Abuse Treatment Program (SATP) at the Atlanta Veterans Affairs Medical Center (VAMC) in Decatur, Georgia. Non-alcoholic subjects were matched by age, gender, race, and smoking status. Greater detail regarding the study population and enrollment procedures is available in the online supplement.
Bronchoscopy procedure and bronchoalveolar lavage (BAL) fluid processing.
All study subjects underwent a bronchoscopy and BAL for collection of alveolar macrophages using standard techniques that have been previously described (31) and further procedural details are provided in the online supplement. BAL fluid was passed through sterile gauze and centrifuged at 8000 rpm for 5 min. The cell pellets contained predominantly alveolar macrophages with ~90% purity as measured by Diff-Quik (Dade Behring, Deerfield, IL) and were re-suspended at a concentration of 1 x 10 6 cells/ml in RPMI-1640 medium containing 2%
FBS and 1% penicillin/streptomycin and then cultured for 2 hours as previously described (32 
Statistical Analyses.
For statistical comparisons between alcoholic and non-alcoholic subjects, we used general estimating equations with repeated measures to account for the matching design via SAS software's (version 9.3) Genmod procedure (33) and 1-step robust regression estimator weighting to reduce the influence of outliers (34) . Further statistical details are in the online supplement.
Research Ethics.
All 
RESULTS
Subject enrollment.
A total of 375 subjects were screened for enrollment into the study; 175
with an alcohol use disorder and 200 without any history of alcohol abuse [ Figure 1 ]. Among the screened subjects with an alcohol use disorder, 112 met at least one of the exclusion criteria and 46 declined to participate in the study. Among the non-alcoholics who were screened, 118 met at least one of the exclusion criteria, 10 declined to participate, and 55 did not have a match among the alcoholic subjects. Overall, 17 subjects with an active AUD and 17 matched nonalcoholics subjects were enrolled and underwent bronchoscopy. There was improper handling of one BAL sample from an alcoholic subject that rendered it unusable. All other samples were analyzed as described in Methods.
Subject characteristics. Alcoholic and non-alcoholic subjects were similar for gender and race (both groups were all male and 88% were Black/African-American), average age (45.2 vs. 45.8 years), and body mass index (28.0 vs. 28.6 kg/m 2 ). [ Table 1 ] Eighty-eight percent of both groups smoked cigarettes; however, those in the alcoholic group smoked more heavily (medians:
360 v 150 cigarettes in the previous 30 days). Illegal drug use was reported by 7 (44%) of the alcoholic subjects but not by any of the control subjects. Per the inclusion criteria, all alcoholic subjects had a current alcohol use disorder and were actively drinking at the time of enrollment (mean SMAST score (se): 6.9 (3.4)), whereas the control subjects were either non-drinkers or drank socially but did not meet criteria for an AUD (mean SMAST score (se): 0.9 (0.7)). The median alcohol intake (in grams/day) for non-alcoholics was zero and 126 among alcoholic subjects. The median time since the most recent alcohol drink was one day in the alcoholic subjects and 14 days in the control subjects.
Alveolar macrophages isolated from subjects with an alcohol use disorder had lower intracellular zinc levels. We previously determined that extracellular and intracellular zinc levels are decreased in an experimental animal model of chronic alcohol ingestion (27) . In human subjects, we evaluated intracellular zinc status since extracellular zinc measurements in lavage fluid would be difficult to interpret given variations in sample dilution. Alveolar macrophages isolated from alcoholic subjects had lower intracellular zinc levels compared to alveolar macrophages isolated from their matched control subjects (adjusted means (se): 718 (41) vs. 948
(25) RFU/cell; p <0.0001) [see Figure 2A and Table 2 ].
In contrast, serum zinc levels did not differ between alcoholic and control subjects and did not correlate with alveolar macrophage zinc levels. There were no appreciable differences in serum zinc levels between the alcoholic subjects and the matched control subjects [ Figure 3 , Panel A
and Table 2 ]. In fact, the serum zinc levels were within the normal range in all of the subjects. Alveolar macrophages from alcoholic subjects had decreased bacterial phagocytic capacity.
Previously, we showed that alveolar macrophages isolated from alcohol-fed animals had decreased bacterial phagocytic function compared to alveolar macrophages from control-fed animals (27) . To confirm the relevance of these findings, we compared the relative bacterial phagocytic capacities of alveolar macrophages isolated from human alcoholic and non-alcoholic subjects. The bacterial phagocytic function of alveolar macrophages was more than 30% lower in alcoholics as compared to non-alcoholics (adjusted means (se): 1027 (48) (13, 19) . In this study, the relative expression of GM-CSFRα in the alveolar macrophages did not differ significantly between alcoholic and non-alcoholic control subjects [ Figure 5 , Panel A and Table 2 ]. However, the expression of the GM-CSFRβ subunit was decreased by more than 30% in the alveolar macrophages from the alcoholic subjects as compared to control subjects (adjusted means (se): 1471(42) vs. 2114 (35) RFU/cell; p <0.001)
[ Figure 5 , panel B and Table 2 ].
Treating isolated alveolar macrophages with zinc acetate and/or glutathione in vitro increased intracellular zinc levels and phagocytic capacity, and these salutary effects were most pronounced in response to combination treatment. Previously we determined that treating alveolar macrophages isolated from alcohol-fed experimental animals with either glutathione precursors (i.e., procysteine) or zinc increased their phagocytic function (17, 27) . More recently, we determined that dietary zinc supplementation in alcohol-fed animals normalized alveolar redox balance and restored lung bacterial clearance (21) . Taken together, these experimental findings revealed a dynamic dependence between zinc bioavailability and oxidative stress within the alveolar macrophage. However, these experimental findings have not been extended to humans. Therefore, we treated alveolar macrophages from alcoholic and control subjects with zinc acetate, glutathione, or both in vitro and compared their intracellular zinc levels and bacterial phagocytic capacities after these treatments.
Treatment with either zinc acetate or glutathione increased the intracellular zinc levels in alveolar macrophages from both alcoholic and control subjects [ Figure 6 , Panel A].
Interestingly, there was an even greater increase in the intracellular zinc levels when zinc and GSH were used in combination. In fact, under this treatment the intracellular zinc levels were slightly higher in the alveolar macrophages from the alcoholic subjects compared to the control subjects (adjusted means (se): 2684 (47) vs. 2512 (41) RFU/cell, p=0.0031) [ Table 2 ].
In parallel, increased intracellular zinc levels were associated with salutary effects on bacterial phagocytic function [ Figure 6 , Panel B]. Treatment with either zinc acetate or glutathione increased phagocytic capacity in the alveolar macrophages from alcoholic and control subjects.
Also consistent with intracellular zinc levels, the combination treatment produced the largest improvement in alveolar macrophage phagocytic function, and phagocytosis was not significantly different between the alveolar macrophages from alcoholic and control subjects following this treatment (adjusted means (se): 2453 (60) vs. 2560 (30) RFU/cell, p=0.1188)
[ Table 2 ].
DISCUSSION
In this study we determined that alveolar macrophages of otherwise healthy alcoholic subjects have significantly decreased intracellular zinc levels compared to macrophages of nonalcoholic control subjects even in the presence of normal serum zinc levels. Further, we confirmed that features of the alcoholic lung phenotype identified in the animal model, namely alveolar macrophage immune dysfunction and decreased GM-CSF receptor expression, also occur in human subjects. Finally, treatment of isolated alveolar macrophages from alcoholic subjects with either zinc or GSH in vitro increased intracellular zinc levels and alveolar macrophage phagocytic function. Taken together, these results provide new evidence that chronic alcohol abuse, even in the absence of clinically apparent zinc deficiency or end-organ damage, causes significant zinc depletion and immune dysfunction within the alveolar space.
Therefore, this study extends our basic understanding of the association between alcoholism and pulmonary outcomes such as pneumonia (35, 36) and suggests that increasing zinc and glutathione bioavailability within the alveolar space with dietary supplements could mitigate these pathophysiological consequences.
Zinc deficiency has been established in alcoholic liver disease for over 50 years (37, 38) .
These individuals have significantly lower serum zinc levels compared to non-alcoholic controls (39) , and both human studies and animal models of chronic alcohol ingestion demonstrate the presence of zinc deficiency in hepatocytes (40) (41) (42) . However, much less is known about zinc balance in alcoholics without liver disease, and to our knowledge, the pulmonary zinc status in these individuals has never been examined. This is an important area for research since zinc therapy remains absent from clinical practice guidelines involving the management of alcoholrelated disorders including alcohol withdrawal (43) . In this study, our alcoholic and control subjects all had normal blood zinc levels, suggesting that these serum measurements are unreliable surrogate markers for zinc metabolism at the organ level. Specifically, alveolar macrophage intracellular zinc was about 30% lower in alcoholic subjects compared to matched non-alcoholics in this study. While the clinical relevance of this finding requires additional investigation, this degree of intracellular zinc depletion has been shown to cause significant cellular and clinical derangements in other studies (44) (45) (46) . Further, our clinical findings in this study are remarkably consistent with our published findings in an animal model of chronic alcohol ingestion in which we identified a similar 30% decrease in lung zinc levels, and where correction of this deficiency reversed phagocytic dysfunction in the alveolar macrophage and restored lung bacterial clearance (21, 27 ).
Animal models have been instrumental in characterizing what we have termed the
'alcoholic lung phenotype', which includes increased oxidative stress in the lower airways, immune dysfunction of the alveolar macrophage, and disruption of alveolar epithelial barrier function (7) . Human studies are limited, but have confirmed the presence of oxidative stress in the alveolar space (47) and revealed alteration of gene expression in alveolar macrophages isolated from alcoholics (48) . In this study, we show that isolated macrophages from human alcoholics have significantly decreased phagocytic capacity compared to matched controls. This finding is parallel to our observations in the animal model and confirms the presence of alcoholinduced immune dysfunction in the human lung. We have shown previously that decreased GM-CSF signaling secondary to alcohol exposure is at least partly responsible alveolar macrophage immune impairment in the rat lung (13, 19) . Interestingly, correction of zinc deficiency improved GM-CSF signaling in this model (27) , suggesting that these two pathways may be interdependent. We evaluated the role of the GM-CSF pathway in the human lung, and we found that subjects with an AUD exhibit significantly decreased alveolar macrophage GM-CSF receptor β-subunit expression compared to matched controls and no difference in α-subunit expression. This is a similar albeit not a complete recapitulation of our findings in the animal model in which there was decreased expression of the signaling component receptor β-subunit but also of the ligand binding receptor α-subunit. The decreased expression of the β-subunit we identified in these human subjects suggests that the dampened GM-CSF signaling we discovered in the experimental model (including decreased expression and nuclear binding of its master transcription factor, PU.1) may contribute to alcohol-induced macrophage dysfunction in humans. Admittedly, we did not identify a significant decrease in expression of the α-subunit in the macrophages from alcoholic subjects as we had in the experimental model. Although an explanation for this difference is at present unknown, our findings nevertheless support the hypothesis that alcohol abuse dampens GM-CSF signaling in human alveolar macrophages as the GM-CSF receptor requires optimal expression of the β-subunit to initiate intracellular signaling.
There are no currently available treatments to mitigate the adverse effects of chronic alcohol use on the lung. Animal models have shown that dietary supplementation with zinc and thiol anti-oxidants (particularly glutathione precursors) may have a therapeutic role, but to date no human trials have been done. The use of these modalities is of particular interest as we previously showed that zinc deficiency and oxidative stress are mechanistically connected.
Specifically, other investigators have described the close relationship between oxidative stress and zinc deficiency (49, 50) , and we determined that correction of zinc deficiency improves redox stress in the lower airway of alcohol-fed animals (21) . In this human study, treating isolated alveolar macrophages with zinc and/or GSH in vitro improved their intracellular zinc levels and phagocytic function in parallel. Understandably, this is not the same as dietary supplementation, but these experiments provide important proof-of-concept for the development of clinical trials. Interestingly, GSH appears to improve intracellular zinc levels, strengthening the argument that zinc and oxidative stress pathways are interconnected. While these parameters also improved in alveolar macrophages isolated from control subjects, when cells are treated with both zinc and GSH there is no appreciable difference in zinc levels or phagocytic function between the two groups.
While this study furthers our knowledge of the alcoholic lung phenotype in human subjects, it has some limitations. First, this is a relatively small, single-center study, making it difficult to control for many potential confounding factors simultaneously. Due to the nature of the veteran population at our center, all enrolled subjects were male and most were African American, which limits generalizability. Despite these limitations, we attempted to control for confounding by matching. Our alcoholic subjects were heavier smokers in general, and we adjusted our analysis to control for the number of cigarettes smoked in the last month even though the unadjusted analysis does not alter the conclusion reached in this study. Second, the clinical importance of measuring intracellular zinc levels is not known and such testing is not commercially available for individuals seen by health care providers. Currently, the evaluation of pulmonary zinc status is on a research basis only and requires a relatively invasive technique (i.e. bronchoscopy) to perform. However, our experimental studies show that alveolar zinc deficiency correlates with the levels of glutathione, which can be measured non-invasively with exhaled breath condensate. It may be feasible in the future to employ such methods as surrogate markers of alveolar 'health'.
In summary, this study furthers our understanding of the effects of alcoholism on the human lung. Specifically, we demonstrate that intracellular zinc levels are significantly decreased in alveolar macrophages from alcoholic subjects compared to non-alcoholics even when serum zinc levels are normal. In parallel, alveolar macrophages from alcoholic subjects have impaired immune function as characterized by decreased GM-CSF receptor (β-subunit) expression and decreased phagocytic capacity. Importantly, treating these dysfunctional macrophages with zinc and GSH in vitro restored their intracellular zinc levels and phagocytic function, providing provocative evidence that it is not the alcohol per se, but rather the alcohol- 
